Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
China - Hong Kong SAR 1996-2001180127.315.213.728.417.016.517.219.9
China - Qidong 1992-200066111.96.86.512.47.68.08.66.7
China - Shangai 1992-1995224216.27.36.516.98.17.88.59.5
China - Tianjin 1991-1999199036.426.025.237.628.629.830.331.0
India - Chennai 1990-199932826.611.67.927.512.79.16.98.7
India - Karunagappally 1991-19974112.22.42.412.62.73.02.84.3
India - Mumbai 1992-199491722.915.712.523.817.414.613.215.2
Singapore 1993-199751211.55.33.412.05.84.04.14.8
Republic of Korea - Busan 1996-2001101121.97.55.522.48.16.36.57.4
Republic of Korea - Incheon 1997-200151821.911.911.022.512.712.311.314.2
Republic of Korea - Seoul 1993-1997180726.114.413.126.815.615.015.617.1
Thailand - Chiang Mai 1993-199710618.210.610.618.411.011.614.710.6
Thailand - Lampang 1990-200015822.814.613.923.115.115.015.115.0
Thailand - Songkhla 1990-19998441.915.012.242.515.513.08.715.9



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period